Clinical trial
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus…
NCT00054938 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00054938 |
|---|---|
| Title | Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) |
| Official title | A Randomized Controlled Trial of Strategies for the Prevention of Accelerated Atherosclerosis in Systemic Lupus Erythematosus - A Pilot Study |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus, Lupus |
| Intervention type | Behavioral, Drug |
| Interventions | pravastatin, aspirin, ramipril, Vitamins: B6, B12, and folate, heart health educational program |
| Enrollment | 150 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Feb 14, 2003 |
| Last update posted | Dec 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: